3Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Muhicenter clinical evaluation of the ( 1-3 ) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans [ J ]. Clin Infect Dis, 2005, 41(5) : 654 -659.
4Hachem RY, Kontoyiannis DP, Chemaly RF, et al. Utility of ga- lactomannan enzyme immunoassay and (1,3) beta-D-glucan in di- agnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients[J]. J Clin Microbiol, 2009, 47( 1 ) : 129 - 133.
5Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich en- zyme-linked immunosorbent assay for galactomannan, and a ( 1- 3 ) -beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders [ J ]. J Clin Microbiol, 2004, 42(6) : 2733 -2741.
8Horger M. Hebart H. Einsele H. et al. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non HIV immunocompro- raised patients:association with patient outcome[J], Eur J Radiol. 2005,55(3) :437-444.
9Brodoefel H,Vogel M.Hehart H,et al. Longqerm CT follow up in 10 non HIV immunoeompromised patients with invasive pulmonary aspergiliosis: kinetics of CT morphology and correlation with clinical findings and outcorne[J]. A JR,2006. 187(2):404-413.
10Silva RF. Chagter 8 : fungal infections in immunocompronaised patients[J]. J Bras Pneumol.2010.36(1) :142-147.
